New research indicates that individuals who discontinue popular weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who end traditional diet and exercise programs.
Findings released in a prominent medical journal shows that while obese people can lose substantial amounts of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"People using such treatments should be aware of the potential of quick weight regain when the medication ends," cautioned expert Dr. Susan Jebb.
Such speed of regain implies a return to starting mass within about a year and a half.
Comparing Therapies
The research, which reviewed 37 of studies involving over 9,000 of participants, compared the outcomes of the injectable medications with conventional dieting.
Scientists emphasize that people who shed pounds through diet and exercise generally experience a more gradual creep back—approximately 0.1 kg a month—post-intervention.
Understanding the Quick Regain
Experts believe the mechanism of the jabs explains the accelerated weight return.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Artificially providing the hormone levels far above than normal may cause the body to produce less of its own natural hormone, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' results in appetite is no longer kept in check, making binge eating far more likely."
A Chronic Condition?
Health authorities suggest the jabs for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
Many experts contend that, due to the significant potential of weight regain, the treatment should be considered life-long.
This view is supported by drug manufacturers, who say that the findings "underscore the long-term character of excess weight," comparing it to managing conditions like high blood pressure.
User Testimonies
People who have come off the medication explain a intense return of cravings.
"I experienced something flipping and you're instantly ravenous," recalled a patient.
This difficulty is exacerbated if patients have not established sustainable dietary or behavioural modifications during therapy.
Widespread Use
Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand continuing to grow.
- Use is more common among females than males.
- The middle-aged demographic shows the highest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, researchers stress that while the jabs are effective agents for shedding pounds, they are not a magic cure and lasting health benefits relies on ongoing lifestyle changes.
